Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

TBPH — Theravance Biopharma Inc

EXPENSIVE (MOS Model unreliable) · Quality 72/100

Value Score 30 days ago: 15.9 → today 15.9

TBPH - Theravance Biopharma Inc
Data generated 2026-11-11 21:49 UTC (nightly scan, universe: Russell 3000).
Price: 17.03 USD
Intrinsic value: 1.66 USD
Margin of safety: Model unreliable
Implied growth (reverse DCF): +52.4% (model assumes +5.9%)
Valuation: EXPENSIVE
Value Score: 15.9
Quality: 72/100
Moat score: 31 (erosion: none)
EXPENSIVE (MOS Model unreliable) - Quality 72/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/TBPH
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

17.03

Intrinsic value

1.66

Margin of safety

Model unreliable

Implied growth (reverse DCF)

+52.4%

model assumes +5.9%

Value Score

15.9

Quality

Psychology

Discovery

price/volume attention only

Moat score

erosion: none

Value Score: bottom 27% of Russell 3000 · Quality: top 12%

Open the interactive Deep Dive for TBPH →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/TBPH - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is TBPH undervalued?

As of 2026-11-11, TBPH trades at 17.03 against a computed intrinsic value of 1.66 (-925.9% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Theravance Biopharma Inc's Value Score?

Theravance Biopharma Inc's Value Score is 15.9 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.